We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-9.02%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.54B
AUM Growth
-$187M
Cap. Flow
+$195K
Cap. Flow %
0.01%
Top 10 Hldgs %
16.48%
Holding
333
New
25
Increased
139
Reduced
93
Closed
34

Top Sells

Rank Stock Value
1
DBD
Diebold Nixdorf Incorporated
DBD
+$18.1M
2
STKL
SunOpta
STKL
+$15.4M
3
MAGN
Magnera Corp
MAGN
+$13.9M
4
FCFS icon
FirstCash
FCFS
+$12.9M
5
KN icon
Knowles
KN
+$7.68M

Sector Composition

Rank Sector Weight
1 Industrials 19.53%
2 Technology 15.58%
3 Consumer Discretionary 15.16%
4 Healthcare 14.52%
5 Financials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMWP
201
DELISTED
Eros Media World PLC
EMWP
$1.52M 0.1%
2,796
-1,975
-41% -$1.26M
INGN icon
202
Inogen
INGN
$164M
$1.52M 0.1%
31,283
+500
+2% +$23.7K
FC icon
203
Franklin Covey
FC
$246M
$1.51M 0.1%
94,282
+4,799
+5% +$82.8K
ONTO icon
204
Onto Innovation
ONTO
$15.3B
$1.49M 0.1%
122,709
+2,600
+2% +$36.8K
NVGS icon
205
Navigator Holdings
NVGS
$1.28B
$1.48M 0.1%
+111,127
New +$1.84M
HCCI
206
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$1.48M 0.1%
144,077
+2,000
+1% +$24.7K
ATRO icon
207
Astronics
ATRO
$3.84B
$1.48M 0.1%
66,669
+912
+1% +$28.4K
MED icon
208
Medifast
MED
$141M
$1.45M 0.09%
54,083
-18,378
-25% -$535K
VECO icon
209
Veeco
VECO
$3.23B
$1.45M 0.09%
+70,807
New +$1.71M
IWO icon
210
iShares Russell 2000 Growth ETF
IWO
$15.1B
$1.45M 0.09%
10,790
-1,343
-11% -$199K
GSIG
211
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
$1.43M 0.09%
112,162
+1,500
+1% +$20.3K
RLYP
212
DELISTED
RELYPSA INC COM
RLYP
$1.42M 0.09%
76,604
+13,134
+21% +$361K
GEN
213
DELISTED
Genesis Healthcare, Inc.
GEN
$1.42M 0.09%
+231,088
New +$1.57M
STRL icon
214
Sterling Infrastructure
STRL
$16.7B
$1.41M 0.09%
343,331
+223,804
+187% +$1.02M
CPLA
215
DELISTED
Capella Education Company
CPLA
$1.4M 0.09%
28,294
-300
-1% -$15.3K
AERI
216
DELISTED
Aerie Pharmaceuticals
AERI
$1.39M 0.09%
+78,376
New +$1.42M
ABBV icon
217
AbbVie
ABBV
$435B
$1.32M 0.09%
24,309
TRAK icon
218
ReposiTrak
TRAK
$159M
$1.32M 0.09%
124,486
+1,430
+1% +$17.4K
TYPE
219
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$1.29M 0.08%
59,217
+10,371
+21% +$238K
ITRN icon
220
Ituran Location and Control
ITRN
$1.05B
$1.29M 0.08%
62,732
+3,553
+6% +$86.5K
KITE
221
DELISTED
Kite Pharma, Inc.
KITE
$1.26M 0.08%
+22,725
New +$1.43M
XOM icon
222
ExxonMobil
XOM
$634B
$1.23M 0.08%
16,486
TISI icon
223
Team
TISI
$77.7M
$1.2M 0.08%
+3,748
New +$1.6M
HBIO icon
224
Harvard Bioscience
HBIO
$29.2M
$1.19M 0.08%
31,410
+340
+1% +$15.8K
SQI
225
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
$1.18M 0.08%
118,000
-27,354
-19% -$333K

Similar funds

Rice Hall James & Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Rice Hall James & Associates held 333 positions worth $1.54B, down 11% from $1.73B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Rice Hall James & Associates's Q3 2015 filing shows 25 new, 139 increased, 93 reduced and 34 closed positions. Its largest new stake was Pegasystems: 1,394,762 shares worth $17.2M. The largest sale was Diebold Nixdorf Incorporated, an estimated $18.1M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Rice Hall James & Associates's largest Q3 2015 buy was Pegasystems: 1,394,762 shares worth $17.2M.
  • Rice Hall James & Associates added most to Tetra Tech in Q3 2015, an estimated $18.3M increase.
  • Rice Hall James & Associates's biggest Q3 2015 reduction was AMN Healthcare, cutting an estimated $7.06M.
  • Rice Hall James & Associates fully exited Diebold Nixdorf Incorporated in Q3 2015, selling an estimated $18.1M.
  • Rice Hall James & Associates's ten largest holdings make up 16% of its $1.54B portfolio in Q3 2015.
  • Rice Hall James & Associates opened 25 new positions and closed 34 in Q3 2015.
  • Rice Hall James & Associates's portfolio value fell 11% quarter-over-quarter to $1.54B.

Based on Rice Hall James & Associates's 13F filing for Q3 2015, filed 30 Oct 2015.